Evidence map›Paper›PMID 33312677›Full record

ArticleNeuro-oncology practice2020

Impact of proton radiotherapy on treatment timing in pediatric and adult patients with CNS tumors.

Michael C Jin, Siyu Shi, Adela Wu, Navjot Sandhu, Michael Xiang, Scott G Soltys, Susan Hiniker, Gordon Li, Erqi L Pollom

Open access · greenAbstract read
In one paragraph

Article in Neuro-oncology practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Michael C JinDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
Siyu ShiDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
Adela WuDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Navjot SandhuDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
Michael XiangDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
Scott G SoltysDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
Susan HinikerDepartment of Radiation Oncology, Stanford University School of Medicine, Stanford, California.
Gordon LiDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Erqi L PollomPalo Alto Veterans Affairs Health Care System, Palo Alto, California.
Stanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite putative benefits associated with proton radiotherapy in the setting of CNS tumors, numerous barriers limit treatment accessibility. Given these challenges, we explored the association of proton use with variations in treatment timing.

methodsPediatric and adult patients with histologically confirmed CNS tumors were identified from the National Cancer Database (2004-2015). Univariable and multivariable regression models were constructed to assess factors impacting radiation timing. Multivariable Cox regression was used to evaluate the effect of treatment delay on survival.

resultsA total of 76 157 patients received photon or proton radiotherapy. Compared to photons, time to proton administration was longer in multiple pediatric (embryonal, ependymal, nonependymal glial, and other) and adult (ependymal, nonependymal glial, meningeal, other) tumor histologies. On adjusted analysis, proton radiotherapy was associated with longer delays in radiotherapy administration in pediatric embryonal tumors (+3.00 weeks,

conclusionsProton radiotherapy is associated with later radiation initiation in pediatric and adult patients with CNS tumors. In patients with high-risk CNS malignancies receiving protons, delayed adjuvant radiotherapy is associated with poorer survival. Further studies are needed to understand this discrepancy to maximize the potential of proton radiotherapy for CNS malignancies.

Indexed as

central nervous systemparticle therapyproton therapyradiation therapytreatment planning

Identifiers

PMID33312677
PMCPMC7716142
OpenAlexW3035872786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.